Symptoms of gastro-oesophageal reflux: Prevalence, severity, duration and associated factors in a Spanish population

Alimentary Pharmacology and Therapeutics

Volumn 19, Issue 1, 2004, Pages 95-105

  Diaz Rubio, M ^a,d   Moreno Elola Olaso, C ^a   Rey, E ^a   Locke III, G R ^b   Rodriguez Artalejo, F ^c  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b MAYO CLINIC   (United States)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH SURVEY; HEARTBURN; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OBESITY; OUTCOMES RESEARCH; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PSYCHOSOMATIC DISORDER; QUESTIONNAIRE; REFLUX ESOPHAGITIS; REGRESSION ANALYSIS; RISK; RISK FACTOR; SPAIN; STATISTICAL SIGNIFICANCE; TELEPHONE;

ADULT; AGED; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; SPAIN;

EID: 1642574279     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01769.x     Document Type: Article

References (37)

1. Ruth M. Mansson I, Sandberg N. The prevalence of symptoms suggestive of esophageal disorders. Scand J Gastroenterol 1991; 26: 73-81.
2. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569-80.
3. Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population. Ann Med 1995; 27: 67-70.
4. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-56.
5. Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 2000; 14: 1589-94.
6. Haque M, Wyeth JW, Stace NH, Talley NJ, Green R. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. N Z Med J 2000; 113: 178-81.
7. Louis E, DeLooze D, Deprez P, et al. Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources. Eur J Gastroenterol Hepatol 2002; 14: 279-84.
8. Romero Y, Cameron AJ, Locke GR III, et al. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 1997; 113: 1449-56.
9. Trudgill NJ, Kapur KC, Riley SA. Familial clustering of reflux symptoms. Am J Gastroenterol 1999; 94: 1172-8.
10. Cameron AJ, Lagergren J, Henriksson C, Nyren O, Locke GR III, Pedersen NL. Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology 2002; 122: 55-9.
11. Romero Y, Locke GR III. Is there a GERD gene? Am J Gastroenterol 1999; 94: 1127-9.
12. Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 1999; 106: 642-9.
13. Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl 1999; 231: 20-8.
14. Lagergren J, Bergstrom R, Nyren O. No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut 2000; 47: 26-9.
15. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ III. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992; 136: 165-77.
16. Kay L, Jorgensen T. Epidemiology of upper dyspepsia in a random population. Prevalence, incidence, natural history, and risk factors. Scand J Gastroenterol 1994; 29: 2-6.
17. Locke GR,Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 539-47.
18. Moreno Elola-Olaso C, Rey E, Rodriguez-Artalejo F, Locke GR III, Diaz-Rubio M. Adaptation and validation of a gastroesophageal reflux questionnaire for use on a Spanish population. Rev Esp Enf Dig 2002; 94: 745-51.
19. Farup C, Kleinman L, Sloan S, et al. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med 2001; 161: 45-52.
20. Bolin TD, Korman MG, Hansky J, Stanton R. Heartburn: community perceptions. J Gastroenterol Hepatol 2000; 15: 35-9.
21. Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol 1998; 93: 1816-22.
22. Eggleston A, Farup C, Meier R. The Domestic/International Gastroenterology Surveillance Study (DIGEST): design, subjects and methods. Scand J Gastroenterol Suppl 1999; 231: 9-14.
23. Oliveria SA, Christos PJ, Talley NJ, Dannenberg AJ. Heartburn risk factors, knowledge, and prevention strategies: a population-based survey of individuals with heartburn. Arch Intern Med 1999; 159: 1592-8.
24. Stanghellini V. Relationship between upper gastrointestinal symptoms and lifestyle, psychosocial factors and comorbidity in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl 1999; 231: 29-37.
25. Baker LH, Lieberman D, Oehlke M. Psychological distress in patients with gastroesophageal reflux disease. Am J Gastroenterol 1995; 90: 1797-803.
26. Song CW, Lee SJ, Jeen YT, et al. Inconsistent association of esophageal symptoms, psychometric abnormalities and dysmotility. Am J Gastroenterol 2001; 96: 2312-6.
27. Johnston BT, Gunning J, Lewis SA. Health care seeking by heartburn sufferers is associated with psychosocial factors. Am J Gastroenterol 1996; 91: 2500-4.
28. Hippisley-Cox J, Coupland C, Pringle M, Crown N, Hammersley V. Married couples' risk of same disease: cross sectional study. Br Med J 2002; 325: 636.
29. Kotzan J, Wade W, Yu HH. Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population. Pharm Res 2001; 18: 1367-72.
30. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 1998; 22: 39-47.
31. Gutierrez-Fisac JL, Banegas Banegas JR, Rodriguez-Artalejo F, Regidor E. Increasing prevalence of overweight and obesity among Spanish adults, 1987-1997. Int J Obes Relat Metab Disord 2000; 24: 1677-82.
32. Chow WH, Finkle WD, McLaughlin JK, Frankl H, Ziel HK, Fraumeni JF Jr. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. J Am Med Assoc 1995; 274: 474-7.
33. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31.
34. Farrow DC, Vaughan TL, Sweeney C, et al. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control 2000; 11: 231-8.
35. Wendl B, Pfeiffer A, Pehl C, Schmidt T, Kaess H. Effect of decaffeination of coffee or tea on gastro-oesophageal reflux. Aliment Pharmacol Ther 1994; 8: 283-7.
36. Brazer SR, Onken JE, Dalton CB, Smith JW, Schiffman SS. Effect of different coffees on esophageal acid contact time and symptoms in coffee-sensitive subjects. Physlol Behav 1995; 57: 563-7.
37. Pandolfino JE, Kahrilas PJ. Smoking and gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2000; 12: 837-42.